SLAMF1 and B-cell chronic lymphocytic leukemia: SLAMF1 is found to regulate the autophagy of patients with chronic lymphocytic leukaemia and influence the response of chronic lymphocytic leukaemia cells to autophagy‐activated therapeutics [36].